Cerra Bruno, Carotti Andrea, Passeri Daniela, Sardella Roccaldo, Moroni Giada, Di Michele Alessandro, Macchiarulo Antonio, Pellicciari Roberto, Gioiello Antimo
Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, I-06123 Perugia, Italy.
TES Pharma, Via Corso Vannucci 47, I-06121 Perugia, Italy.
ACS Med Chem Lett. 2018 Dec 27;10(4):677-681. doi: 10.1021/acsmedchemlett.8b00459. eCollection 2019 Apr 11.
The discovery of lead compounds relies on the iterative generation of structure-activity relationship data resulting from the synthesis and biological evaluation of hit analogues. Using traditional approaches, a significant time delay may occur from compound design to results, leading to slow and expensive hit-to-lead explorations. Herein, we have exploited the use of chemical toolboxes to expedite lead discovery and optimization. In particular, the integration of flow synthesizers, automation, process analytical technologies, and computational chemistry has provided a prototype system enabling the multicomponent flow synthesis, in-line analysis, and characterization of chiral tetracyclic quinolines as a novel class of PXR agonists. Within 29 compounds, a novel template (3a,11,11a) was identified with an EC of 1.2 μM (efficacy 119%) at the PXR receptor.
先导化合物的发现依赖于对命中类似物进行合成和生物学评估所产生的构效关系数据的迭代生成。使用传统方法时,从化合物设计到得出结果可能会出现显著的时间延迟,导致从命中物到先导物的探索缓慢且成本高昂。在此,我们利用化学工具箱来加速先导物的发现和优化。特别是,流动合成仪、自动化技术、过程分析技术和计算化学的整合提供了一个原型系统,能够实现手性四环喹啉作为新型PXR激动剂的多组分流动合成、在线分析和表征。在29种化合物中,鉴定出一种新型模板(3a,11,11a),其在PXR受体上的EC为1.2 μM(效能为119%)。